Sell Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Sell
selectin, lymphocyte
MGI:98279

43 phenotypes from 12 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
\Sell^m1Btlr/\Sell^m1Btlr C57BL/6J-Sell^m1Btlr	decreased single-positive T cell number	J:217794
\Sell^m2Btlr/\Sell^m2Btlr C57BL/6J-Sell^m2Btlr	decreased response to antigen	J:231806
\Sell^m2Btlr/\Sell^m2Btlr C57BL/6J-Sell^m2Btlr	decreased single-positive T cell number	J:231806
\Sell^tm1.1Rpmc/\Sell^tm1.1Rpmc involves: 129S1/Sv * C57BL/6J * FVB/N	abnormal granulocyte physiology	J:249558
	abnormal neutrophil physiology	J:249558
	normal hematopoietic system phenotype	J:249558
	normal immune system phenotype	J:249558
	increased inflammatory response	J:249558
	increased susceptibility to induced thrombosis	J:249558
	normal mortality/aging	J:249558
	normal reproductive system phenotype	J:249558
\Sell^tm1Alb/\Sell^tm1Alb involves: 129S7/SvEvBrd * C57BL/6	extramedullary hematopoiesis	J:70682
	normal integument phenotype	J:70682
	intermingled spleen red and white pulp	J:70682
\Sell^{tm1b(EUCOMM)Hmgu}/\Sell^{tm1b(EUCOMM)Hmgu} C57BL/6N-Sell^{tm1b(EUCOMM)Hmgu}/H	increased spleen weight	J:211773
\Sell^tm1Flv/\Sell⁺ involves: C57BL/6 * NOD	decreased susceptibility to autoimmune diabetes	J:88947
\Sell^tm1Flv/\Sell⁺ involves: C57BL/6 * NOD	pancreas inflammation	J:88947
\Sell^tm1Flv/\Sell⁺ NOD.Cg-Sell^tm1Flv	normal immune system phenotype	J:88974
\Sell^tm1Flv/\Sell^tm1Flv involves: 129S2/SvPas * C57BL/6	abnormal type IV hypersensitivity reaction	J:89253
\Sell^tm1Flv/\Sell^tm1Flv involves: 129S2/SvPas * C57BL/6	decreased activated T cell number	J:89253
\Sell^tm1Flv/\Sell^tm1Flv involves: C57BL/6 * NOD	decreased susceptibility to autoimmune disorder	J:88947
\Sell^tm1Flv/\Sell^tm1Flv involves: C57BL/6 * NOD	pancreas inflammation	J:88947
\Sell^tm1Flv/\Sell^tm1Flv NOD.Cg-Sell^tm1Flv	normal immune system phenotype	J:88974
\Sell^tm1Pest/\Sell⁺ involves: 129S4/SvJae * C57BL/6	abnormal hypersensitivity reaction	J:112550
\Sell^tm1Pest/\Sell⁺ involves: 129S4/SvJae * C57BL/6	impaired leukocyte tethering or rolling	J:112550
\Sell^tm1Pest/\Sell^tm1Pest involves: 129S4/SvJae	abnormal hypersensitivity reaction	J:111233
	abnormal leukocyte adhesion	J:111233
	impaired leukocyte tethering or rolling	J:111233
	increased T cell proliferation	J:111233
\Sell^tm1Pest/\Sell^tm1Pest involves: 129S4/SvJae * C57BL/6	abnormal cell-mediated immunity	J:112550
	abnormal dendritic cell physiology	J:112550
	abnormal hypersensitivity reaction	J:112550
	abnormal leukocyte migration	J:112550
	abnormal splenic cell ratio	J:112550
	decreased T cell proliferation	J:112550
	enlarged spleen	J:112550
	normal immune system phenotype	J:112550
	impaired leukocyte tethering or rolling	J:112550
	lymph node hypoplasia	J:112550
	small popliteal lymph nodes	J:112550
\Sell^tm1Tft/\Sell^tm1Tft B6.129-Sell^tm1Tft	abnormal cellular extravasation	J:66107
\Sell^tm1Tft/\Sell^tm1Tft B6.129-Sell^tm1Tft	abnormal leukocyte migration	J:66107
\Sell^tm1Tft/\Sell^tm1Tft B6.129P2-Sell^tm1Tft	abnormal cellular extravasation	J:48271
	abnormal regulatory T cell number	J:141931
	abnormal regulatory T cell physiology	J:141931
	impaired leukocyte tethering or rolling	J:48271
	increased monocyte cell number	J:48271, J:142184
	increased tumor growth/size	J:108135
	lymph node hypoplasia	J:141931, J:142184
	spleen hyperplasia	J:141931
\Sell^tm1Tft/\Sell^tm1Tft involves: 129P2/OlaHsd * C57BL/6	abnormal cellular extravasation	J:25005
	abnormal leukocyte migration	J:25005
	enlarged spleen	J:25005
	impaired leukocyte tethering or rolling	J:25005
\Sell^tm2.1Tft/\Sell^tm2.1Tft involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal circulating protein level	J:142184
	abnormal neutrophil physiology	J:142184
	spleen hyperplasia	J:142184
\Sell^tm2Hyn/\Sell^tm2Hyn involves: 129S2/SvPas * BALB/c	impaired leukocyte tethering or rolling	J:114317
\Sell^tm2Hyn/\Sell^tm2Hyn involves: 129S2/SvPas * C57BL/6	decreased metastatic potential	J:106671
	decreased monocyte cell number	J:57973
	decreased tumor incidence	J:106671
	normal immune system phenotype	J:106550
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
	normal liver/biliary system phenotype	J:106550
\Sell^tm2Tft/\Sell^tm2.1Tft involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal circulating protein level	J:142184
	abnormal leukocyte migration	J:142184
	abnormal neutrophil physiology	J:142184
	abnormal regulatory T cell number	J:141931
	abnormal regulatory T cell physiology	J:141931
	impaired leukocyte tethering or rolling	J:142184
\Sell^tm2Tft/\Sell^tm2Tft involves: 129S1/Sv * 129X1/SvJ	lymph node hypoplasia	J:142184
\Sell^tm2Tft/\Sell^tm2Tft involves: 129S1/Sv * 129X1/SvJ	spleen hyperplasia	J:142184
\Sell^tm3Tft/\Sell^tm3Tft involves: 129S1/Sv * 129X1/SvJ	abnormal circulating protein level	J:142184

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 03/25/2025 MGI 6.24